No Data Available
Advik Labs - MPS Pharma Share Price
BSE
Loading...
| Open | - |
| High | - |
| Low | - |
| Prev Close | - |
| Volume | - |
| VWAP(₹) | - |
Key Metrics
| PE Ratio(x) | -3.39 |
| EPS - TTM(₹) | -0.53 |
| MCap(₹ Cr.) | 3.46 |
| MCap Rank | - |
| PB Ratio(x) | - |
| Div Yield(%) | - |
| Face Value(₹) | - |
| 52W High(₹) | 4.33 |
| 52W Low(₹) | 0.32 |
| MCap/Sales | - |
| Beta(1 Month) | - |
| BV/Share(₹) | - |
Advik Labs share price insights
Passing Profits to Shareholders
Company has consistently declining ROE in last 5 years. Majority of profits last year were disbursed as dividends to shareholders. (Source: Standalone Financials)PAT: Troublesome Times
Company has posted a loss of Rs 0.36 cr for the 4th consecutive quarter. (Source: Standalone Financials)Losing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)Advik Labs Share Price Update
Share Price Value Today/Current/Last 1.81 Previous Day 1.73
Found Insights useful?
Advik Labs Share Price Returns
| 1 Day | 0.0% |
| 1 Month | N.A. |
| 3 Months | N.A. |
| 1 Year | N.A. |
| 3 Years | -21.65% |
| 5 Years | N.A. |
Advik Labs Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
News & Analysis
Financials
Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Total Income 0.04 0.00 0.00 0.00 0.00 Total Income Growth (%) - - - - -100.00 Total Expenses 0.40 0.23 0.23 0.23 0.23 Total Expenses Growth (%) 76.46 -0.17 0.52 -0.09 3.25 EBIT -0.37 -0.23 -0.23 -0.23 -0.23 EBIT Growth (%) - - - - - Profit after Tax (PAT) -0.36 -0.22 -0.22 -0.22 -0.28 PAT Growth (%) - - - - - EBIT Margin (%) -1,037.08 - - - - Net Profit Margin (%) -1,009.27 - - - - Basic EPS (₹) -0.19 -0.12 -0.12 -0.12 -0.15 All figures in Rs Cr, unless mentioned otherwise
InsightsPAT: Troublesome Times
Company has posted a loss of Rs 0.36 cr for the 4th consecutive quarter. (Source: Standalone Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Total Assets 8.48 9.33 9.94 10.19 10.16 Total Assets Growth (%) -9.11 -6.14 -2.45 0.30 -10.09 Total Liabilities 8.41 8.25 7.97 7.40 6.33 Total Liabilities Growth (%) 1.94 3.51 7.70 16.90 -13.88 Total Equity 0.07 1.08 1.97 2.79 3.83 Total Equity Growth (%) -93.52 -45.18 -29.39 -27.15 -3.04 Current Ratio (x) 0.23 0.25 0.27 0.29 0.33 Total Debt to Equity (x) 109.84 6.90 3.69 2.42 1.52 Contingent Liabilities 0.00 0.04 0.04 - - All figures in Rs Cr, unless mentioned otherwise
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Net Cash flow from Operating Activities -0.59 -0.57 -0.63 -0.87 -4.34 Net Cash used in Investing Activities 0.52 0.38 0.12 -0.10 0.46 Net Cash flow from Financing Activities 0.07 0.18 0.51 0.96 3.88 Net Cash Flow 0.00 0.00 0.00 -0.01 0.00 Closing Cash & Cash Equivalent 0.00 0.00 0.01 0.01 0.01 Closing Cash & Cash Equivalent Growth (%) -43.77 -56.85 -20.50 -46.90 8.73 Total Debt/ CFO (x) -12.76 -13.09 -11.49 -7.82 -1.34 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Return on Equity (%) -1,489.05 -83.08 -42.21 -37.63 -3.70 Return on Capital Employed (%) -363.38 -68.24 -38.85 -35.47 -22.83 Return on Assets (%) -12.02 -9.62 -8.36 -10.31 -1.39 Interest Coverage Ratio (x) -1,137.88 -1,438.08 -563.32 -1,722.46 -373.22 Asset Turnover Ratio (x) - - - - 0.00 Price to Earnings (x) -3.10 -6.78 -7.40 -3.83 -18.80 Price to Book (x) 47.14 5.63 3.12 1.44 0.69 EV/EBITDA (x) -11.73 -18.88 -19.00 -11.65 -20.23 EBITDA Margin (%) 0.00 0.00 0.00 0.00 -1,290.32 InsightsPassing Profits to Shareholders
Company has consistently declining ROE in last 5 years. Majority of profits last year were disbursed as dividends to shareholders. (Source: Standalone Financials)Losing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)
Found Financials useful?
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
Mutual Funds Ownership
No Data Available
Advik Labs Top Searches
Corporate Actions
Board Meeting
Audited Results
May 18, 2026
Board Meeting
Quarterly Results
Jan 22, 2026
Board Meeting
Quarterly Results
Nov 04, 2025
Announced on Meeting on May 18, 2026 May 28, 2026 Audited Results Jan 22, 2026 Feb 02, 2026 Quarterly Results Nov 04, 2025 Nov 14, 2025 Quarterly Results Aug 26, 2025 Sep 02, 2025 A.G.M. Aug 04, 2025 Aug 12, 2025 Quarterly Results No Data Available
No Data Available
No Data Available
Announced on Ex-Date Dec 30, 2003 - Rights ratio: 1 share for every 1 held at a price of Rs 25.0 Announced on Meeting on Sep 11, 2025 Sep 29, 2025 - Sep 09, 2024 Sep 28, 2024 A.G.M. Sep 06, 2023 Sep 29, 2023 A.G.M. Apr 18, 2022 May 18, 2022 (Cancelled) Feb 23, 2022 - (Revised)
About Advik Labs
MPS Pharma Ltd., incorporated in the year 1994, is a Small Cap company (having a market cap of Rs 3.46 Crore) operating in Pharmaceuticals sector.
Show More
Industry
Key Indices Listed On
-
Address
138, Roz-Ka-Meo Industrial Area,Sohna,Mewat Dist., Haryana - 122103
Executive Leadership
PK
Peeyush Kumar Aggarwal
Managing DirectorRN
Ram Niwas Sharma
Non Independent DirectorAS
Ajay Sharma
Independent DirectorMS
Madhu Sharma
Independent DirectorShow More
Auditors
Nemani Garg Agrawal & Co
RMA & Associates LLP
FAQs about Advik Labs share
- 1. What's the Advik Labs share price today?As on 08 Jun, 2026, 04:01 PM IST Advik Labs share price is remain unchanged by N.A. basis the previous closing price of Rs 1.73. Advik Labs share price is Rs 1.81.
- 2. What's the market capitalization of Advik Labs?Advik Labs share has a market capitalization of Rs 3.46 Cr. Within Pharmaceuticals sector, it's market cap rank is -.
- 3. What is Advik Labs's 52 week high / low?52 Week high of Advik Labs share is Rs 4.33 while 52 week low is Rs 0.32
- 4. What is the PE & PB ratio of Advik Labs?The PE ratio of Advik Labs stands at -3.39, while the PB ratio is 50.56.
Top Gainers
As on 04:06 PM | 12 Jun 2026Top Losers
As on 03:58 PM | 12 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.